|
Cancer drug helps combat asthma in mice
EurekAlert (press release) In a mouse model of allergic asthma, dasatinib–an enzyme inhibitor approved for the treatment of chronic myelogenous leukemia–reduced inflammation, enhanced airway repair, and improved lung mechanics. The drug targets tyrosine kinases, which are … |
View full post on asthma – Google News